上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1259Please respect copyright.PENANA3X7sc6ERkl
1259Please respect copyright.PENANA52ZaPx2p1u
上集:https://www.penana.com/article/4711251259Please respect copyright.PENANAhydzA0u9Ec
1259Please respect copyright.PENANAKcpnbmxwSl
1259Please respect copyright.PENANA1Sd64uPSbR
1259Please respect copyright.PENANAZtHbUxk3rw
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1259Please respect copyright.PENANA4YnMHSBXqg
1259Please respect copyright.PENANAMlg47OOmBT
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1259Please respect copyright.PENANA6VP5Ye5B4o
1259Please respect copyright.PENANA8ly2W8F9jw
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1259Please respect copyright.PENANAVB2Mydo02c
1259Please respect copyright.PENANAlRkNBDYnTz
1259Please respect copyright.PENANAIPyUzqSm9i
1259Please respect copyright.PENANAcAlRoARBwm
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1259Please respect copyright.PENANAFHp9LRuIB6
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1259Please respect copyright.PENANAJwU6BLk0EI
1259Please respect copyright.PENANATW3STj5Wv9
忘記甚麼是Neoantigen的話,可重溫上一集。1259Please respect copyright.PENANAA32ZDdQXDc
1259Please respect copyright.PENANAjzqqoIpqwu
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1259Please respect copyright.PENANAYiMhMPNB21
1259Please respect copyright.PENANAinzCkJIpvg
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1259Please respect copyright.PENANAatvFLNp1VW
1259Please respect copyright.PENANA4GG576g5zT
1259Please respect copyright.PENANA8SqXDHmllh
1259Please respect copyright.PENANAbKPRVNJxgf
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1259Please respect copyright.PENANAdA4cTHh8aH
1259Please respect copyright.PENANAzTy7dDwGjP
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1259Please respect copyright.PENANAbRUb8MrE9F
1259Please respect copyright.PENANAtZ2Ujuxd81
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1259Please respect copyright.PENANA5a1Cwp8NYr
1259Please respect copyright.PENANANEEcdehOiJ
1259Please respect copyright.PENANAaWlg5Qi9dz
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1259Please respect copyright.PENANAZgeH8dCPC6
1259Please respect copyright.PENANAeFhhimVy9p
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1259Please respect copyright.PENANAsKxBcGuDQ1
1259Please respect copyright.PENANAc6pCuVNCJs
1259Please respect copyright.PENANAnXJTzI9VC5
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1259Please respect copyright.PENANANbk96m9hFh
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1259Please respect copyright.PENANAn2ZXcU9GPz
1259Please respect copyright.PENANAlp4yjnmMSE
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1259Please respect copyright.PENANA4O5e1yUybh
1259Please respect copyright.PENANAd3D9udeYq1
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1259Please respect copyright.PENANA8aqY62gge2
1259Please respect copyright.PENANAHqWDMN8f9U
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1259Please respect copyright.PENANAzzaOzBlroI
1259Please respect copyright.PENANAMXH1twHF1j
1259Please respect copyright.PENANA5q1FYUWRZ0
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1259Please respect copyright.PENANAZeKc9RE5iT
1259Please respect copyright.PENANAOo1apJmn0h
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1259Please respect copyright.PENANAC1b7C4ytF6
1259Please respect copyright.PENANACj22UWM7Qx
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1259Please respect copyright.PENANAKj9y8BZoPl
1259Please respect copyright.PENANA42yAg0G1NC
Link:1259Please respect copyright.PENANARaTsGxDKnm
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1259Please respect copyright.PENANAyCi8AHDvsP
1259Please respect copyright.PENANAl5zEu257cm
1259Please respect copyright.PENANApmhz2ZlqYM
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1259Please respect copyright.PENANAk6jO4zOmG0